Loading clinical trials...
Loading clinical trials...
Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation: a Placebo-controlled, Double-blinded Randomized Controlled Trial
Conditions
Interventions
Digoxin
Placebo
Locations
3
United States
FPA Women's Health
Long Beach, California, United States
SFGH Women's Options Center
San Francisco, California, United States
Lovejoy Surgicenter
Portland, Oregon, United States
Start Date
February 23, 2017
Primary Completion Date
May 31, 2018
Completion Date
May 31, 2018
Last Updated
October 30, 2019
NCT06821685
NCT06893484
NCT05413525
NCT06787274
NCT06708208
NCT07465016
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions